IL6 and diabetes mellitus: We then conducted longitudinal RT-qPCR validation across pre-exposure, peak-haze, and re-exposure timepoints in adults with and without diabetes, and integrated miRNA profiles with systemic markers (IL-6, CRP, HbA1c, and fasting glucose) to link molecular alterations with clinically relevant phenotypes.